TG2 Identified As Potential Therapeutic Target In Chemo-Resistant Ovarian Cancer M. D. Anderson team silences protein with siRNA, implicates TG2 in fourth cancer Scientists from The University of Texas M. D. Anderson Cancer Center have found overexpression of tissue type transglutaminase (TG2) in ovarian cancer is associated with increased tumor cell growth and adhesion, resistance to chemotherapy and lower overall survival rates.
Source: www.medicalnewstoday.comFood Needs Rise In Eastern Congo And Violence And Displacement Continue The United Nations World Food Programme warned that greater numbers of people fleeing fighting in the eastern Democratic Republic of Congo were stretching the agency's resources to the limit as thousands gather in camps in search of safety.
Source: www.medicalnewstoday.comSt. Jude Medical Announces FDA Approval Of Wireless Transmitter To Monitor Patients' Implanted Cardiac Devices St. Jude Medical, Inc. (NYSE:STJ) announced U.S. Food and Drug Administration (FDA) approval of the Merlin?@home transmitter, an RF wireless technology that remotely monitors patients' implanted cardiac devices. The transmitter supports the St. Jude Medical Current� RF and Promote� RF family of devices and works in conjunction with the St.
Source: www.medicalnewstoday.comMany Teen Smokers Struggle To Kick The Habit Most teenagers who smoke cigarettes make repeated attempts to quit but most are unsuccessful, according to new research from the Universite de Montreal and funded by the Canadian Cancer Society.
Source: www.medicalnewstoday.com
# posted by Network @ 5:00 AM
